| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Urology/Urological Research Laboratories [R. U., T. W. A., F. M. J. D., J. A. S.] and Department of Pathology [H. E. S.], University Hospital Nijmegen, Nijmegen, the Netherlands; James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland [W. B. I., B. S. C.]; and Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands [H. F. M. K.]
E-cadherin is a Ca2+-dependent cell adhesion molecule which plays an important role in normal growth and development via mediation of homotypic, homophilic cell-cell interaction. Recent studies suggest that E-cadherin may be important in neoplastic progression as well, particularly as a suppressor of invasion. We have previously demonstrated that the invasive phenotype of rat prostate cancer cells is associated with the decreased expression of E-cadherin (M. J. G. Bussemakers, R. J. A. Van Moorselaar, L. A. Giroldi, T. Ichikawa, J. T. Isaacs, F. M. J. Debruyne, and J. A. Schalken, Cancer Res., 52: 2916–2922, 1992). This is of particular interest, since the locus to which the human E-cadherin gene is mapped is frequently involved in allelic loss in prostate cancer (B. S. Carter, C. M. Ewing, W. S. Ward, B. F. Treiger, T. W. Aalders, J. A. Schalken, J. I. Epstein, and W. B. Isaacs, Proc. Natl. Acad. Sci. USA, 87: 8751–8755, 1990; U. S. Bergerheim, K. Kunimi, V. P. Collins, and P. Ekman, Genes, Chromosomes Cancer, 3: 215–220, 1991). Impaired E-cadherin function is likely to be associated with aberrant expression of the protein. We therefore analyzed E-cadherin expression in situ by immunohistochemistry in nonmalignant and malignant specimens of human prostatic tissue. Of 92 tumor samples of either primary or metastatic deposits of prostate cancer, 46 had reduced or absent E-cadherin staining when compared to nonmalignant prostate, which uniformly stained strongly positive. There was a statistically significant correlation between the decreased expression of E-cadherin and loss of tumor differentiation. Additionally, certain tumors within a histologically similar group could be distinguished by the presence of mixed populations of E-cadherin-negative and -positive cells. The percentage of tumors with aberrant E-cadherin staining increased when clinically localized tumors were compared to either tumors with extensive local progression or metastatic deposits of prostate cancer, suggesting a correlation between loss of E-cadherin and tumor progression. Taken together, these findings suggest that further exploration of E-cadherin as a candidate invasion suppressor molecule in human prostate cancer is warranted.
1 Supported by grants from the Netherlands Universities Foundation for International Cooperation, van Deventer-Maasstichting (R.U.), and the USPHS (CA5523101 (W.B.I.).
2 To whom requests for reprints should be addressed, at Department of Urology, Marburg 105, Johns Hopkins Hospital, 600 N. Wolfe Street, Baltimore, MD 21205.
Received 6/22/92. Accepted 7/27/92.
This article has been cited by other articles:
|
|
 |
|
  M. S. Elston, A. J. Gill, J. V. Conaglen, A. Clarkson, R. J. Cook, N. S. Little, B. G. Robinson, R. J. Clifton-Bligh, and K. L. McDonald Nuclear Accumulation of E-Cadherin Correlates with Loss of Cytoplasmic Membrane Staining and Invasion in Pituitary Adenomas J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1436 - 1442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-W. Chien, S.-C. Lin, Y.-Y. Lai, B.-W. Lin, S.-C. Lin, J.-C. Lee, and S.-J. Tsai Regulation of CD151 by Hypoxia Controls Cell Adhesion and Metastasis in Colorectal Cancer Clin. Cancer Res., December 15, 2008; 14(24): 8043 - 8051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Wang, J. Wang, and M. D. Sadar Crosstalk between the Androgen Receptor and {beta}-Catenin in Castrate-Resistant Prostate Cancer Cancer Res., December 1, 2008; 68(23): 9918 - 9927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Sardana, B. Dowell, and E. P. Diamandis Emerging Biomarkers for the Diagnosis and Prognosis of Prostate Cancer Clin. Chem., December 1, 2008; 54(12): 1951 - 1960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Zhang, K. Pan, Z. Liu, J. Zhou, L. Gu, J. Ji, J. Ma, W.-c. You, and D. Deng Genetic Polymorphisms of the E-Cadherin Promoter and Risk of Sporadic Gastric Carcinoma in Chinese Populations Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2402 - 2408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Chu, C.-J. Cheng, X. Ye, Y.-C. Lee, A. J. Zurita, D.-T. Chen, L.-Y. Yu-Lee, S. Zhang, E. T. Yeh, M. C-T. Hu, et al. Cadherin-11 Promotes the Metastasis of Prostate Cancer Cells to Bone Mol. Cancer Res., August 1, 2008; 6(8): 1259 - 1267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Maitland and A. T. Collins Prostate Cancer Stem Cells: A New Target for Therapy J. Clin. Oncol., June 10, 2008; 26(17): 2862 - 2870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Lin, A. Watahiki, J. Bayani, F. Zhang, L. Liu, V. Ling, M. D. Sadar, J. English, L. Fazli, A. So, et al. ASAP1, a Gene at 8q24, Is Associated with Prostate Cancer Metastasis Cancer Res., June 1, 2008; 68(11): 4352 - 4359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. Ricke, S. J. McPherson, J. J. Bianco, G. R. Cunha, Y. Wang, and G. P. Risbridger Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling FASEB J, May 1, 2008; 22(5): 1512 - 1520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Gomez, A. de las Pozas, T. Reiner, K. Burnstein, and C. Perez-Stable Increased expression of cyclin B1 sensitizes prostate cancer cells to apoptosis induced by chemotherapy Mol. Cancer Ther., May 1, 2007; 6(5): 1534 - 1543. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Chu, M.-T. Ling, H. Feng, H. W. Cheung, S. W. Tsao, X. Wang, and Y. C. Wong A novel anticancer effect of garlic derivatives: inhibition of cancer cell invasion through restoration of E-cadherin expression Carcinogenesis, November 1, 2006; 27(11): 2180 - 2189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-S. Annicotte, I. Iankova, S. Miard, V. Fritz, D. Sarruf, A. Abella, M.-L. Berthe, D. Noel, A. Pillon, F. Iborra, et al. Peroxisome Proliferator-Activated Receptor {gamma} Regulates E-Cadherin Expression and Inhibits Growth and Invasion of Prostate Cancer. Mol. Cell. Biol., October 1, 2006; 26(20): 7561 - 7574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S Perry, R. Foley, K. Woodson, and M. Lawler The emerging roles of DNA methylation in the clinical management of prostate cancer. Endocr. Relat. Cancer, June 1, 2006; 13(2): 357 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dalrymple, L. Antony, Y. Xu, A. R. Uzgare, J. T. Arnold, J. Savaugeot, L. J. Sokoll, A. M. De Marzo, and J. T. Isaacs Role of Notch-1 and E-Cadherin in the Differential Response to Calcium in Culturing Normal versus Malignant Prostate Cells Cancer Res., October 15, 2005; 65(20): 9269 - 9279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Hughes, A Murphy, C Martin, O Sheils, and J O'Leary Molecular pathology of prostate cancer J. Clin. Pathol., July 1, 2005; 58(7): 673 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. K. Kwok, M.-T. Ling, T.-W. Lee, T. C.M. Lau, C. Zhou, X. Zhang, C. W. Chua, K. W. Chan, F. L. Chan, C. Glackin, et al. Up-Regulation of TWIST in Prostate Cancer and Its Implication as a Therapeutic Target Cancer Res., June 15, 2005; 65(12): 5153 - 5162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. E. Grizzle, D. G. Bostwick, H. Burke, O. W. Tawfik, D. McGregor, J. Cohn, and R. Lieberman Biomarkers in Prostate Cancer Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 196 - 204. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kamoto, Y. Isogawa, Y. Shimizu, S. Minamiguchi, H. Kinoshita, Y. Kakehi, K. Mitsumori, S. Yamamoto, T. Habuchi, T. Kato, et al. Association of a Genetic Polymorphism of the E-cadherin Gene with Prostate Cancer in a Japanese Population Jpn. J. Clin. Oncol., March 1, 2005; 35(3): 158 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rossi, E. Graner, P. Febbo, L. Weinstein, N. Bhattacharya, T. Onody, G. Bubley, S. Balk, and M. Loda Fatty Acid Synthase Expression Defines Distinct Molecular Signatures in Prostate Cancer Mol. Cancer Res., August 1, 2003; 1(10): 707 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bhatia, C. J. Maldonado, S. Tang, D. Chandra, R. D. Klein, D. Chopra, S. B. Shappell, P. Yang, R. A. Newman, and D. G. Tang Subcellular Localization and Tumor-suppressive Functions of 15-Lipoxygenase 2 (15-LOX2) and Its Splice Variants J. Biol. Chem., June 27, 2003; 278(27): 25091 - 25100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kuniyasu, R. Ukai, D. Johnston, P. Troncoso, I. J. Fidler, and C. A. Pettaway The Relative mRNA Expression Levels of Matrix Metalloproteinase to E-Cadherin in Prostate Biopsy Specimens Distinguishes Organ-confined from Advanced Prostate Cancer at Radical Prostatectomy Clin. Cancer Res., June 1, 2003; 9(6): 2185 - 2194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Rhodes, M. G. Sanda, A. P. Otte, A. M. Chinnaiyan, and M. A. Rubin Multiplex Biomarker Approach for Determining Risk of Prostate-Specific Antigen-Defined Recurrence of Prostate Cancer J Natl Cancer Inst, May 7, 2003; 95(9): 661 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Duchesne, S. Charland, C. Asselin, C. Nahmias, and N. Rivard Negative Regulation of beta -Catenin Signaling by Tyrosine Phosphatase SHP-1 in Intestinal Epithelial Cells J. Biol. Chem., April 11, 2003; 278(16): 14274 - 14283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rios-Doria, K. C. Day, R. Kuefer, M. G. Rashid, A. M. Chinnaiyan, M. A. Rubin, and M. L. Day The Role of Calpain in the Proteolytic Cleavage of E-cadherin in Prostate and Mammary Epithelial Cells J. Biol. Chem., January 3, 2003; 278(2): 1372 - 1379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Bianco, D. J. Handelsman, J. S. Pedersen, and G. P. Risbridger Direct Response of the Murine Prostate Gland and Seminal Vesicles to Estradiol Endocrinology, December 1, 2002; 143(12): 4922 - 4933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Rauen, D. Sudilovsky, J. L. Le, K. L. Chew, B. Hann, V. Weinberg, L. D. Schmitt, and F. McCormick Expression of the Coxsackie Adenovirus Receptor in Normal Prostate and in Primary and Metastatic Prostate Carcinoma: Potential Relevance to Gene Therapy Cancer Res., July 1, 2002; 62(13): 3812 - 3818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Yang, X. Li, M. Sharma, C. Y. Sasaki, D. L. Longo, B. Lim, and Z. Sun Linking beta -Catenin to Androgen-signaling Pathway J. Biol. Chem., March 22, 2002; 277(13): 11336 - 11344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Naka, Y Oda, Y Iwamoto, N Shinohara, H Chuman, M Fukui, and M Tsuneyoshi Immunohistochemical analysis of E-cadherin, {alpha}-catenin, {beta}-catenin, {gamma}-catenin, and neural cell adhesion molecule (NCAM) in chordoma J. Clin. Pathol., December 1, 2001; 54(12): 945 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ruiz, P. Troncoso, C. Bruns, and M. Bar-Eli Activator Protein 2{alpha} Transcription Factor Expression Is Associated with Luminal Differentiation and Is Lost in Prostate Cancer Clin. Cancer Res., December 1, 2001; 7(12): 4086 - 4095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Zeitvogel, R. Baumann, and A. Starzinski-Powitz Identification of an Invasive, N-Cadherin-Expressing Epithelial Cell Type in Endometriosis Using a New Cell Culture Model Am. J. Pathol., November 1, 2001; 159(5): 1839 - 1852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ikonen, M. Matikainen, N. Mononen, E.-R. Hyytinen, H. J. Helin, S. Tommola, T. L. J. Tammela, E. Pukkala, J. Schleutker, O.-P. Kallioniemi, et al. Association of E-Cadherin Germ-Line Alterations with Prostate Cancer Clin. Cancer Res., November 1, 2001; 7(11): 3465 - 3471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Smyth, O. Sheils, S. Finn, C. Martin, J. O'Leary, and E. C. Sweeney Real-time Quantitative Analysis of E-cadherin Expression in ret/PTC-1-Activated Thyroid Neoplasms International Journal of Surgical Pathology, October 1, 2001; 9(4): 265 - 272. [Abstract] [PDF]
|
|
|
|
|
|
T. Matsumura, R. Makino, and K. Mitamura Frequent Down-Regulation of E-cadherin by Genetic and Epigenetic Changes in the Malignant Progression of Hepatocellular Carcinomas Clin. Cancer Res., March 1, 2001; 7(3): 594 - 599. [Abstract] [Full Text]
|
|
|
|
|
|
H. Habermann, W. Y. Chang, L. Birch, P. Mehta, and G. S. Prins Developmental Exposure to Estrogens Alters Epithelial Cell Adhesion and Gap Junction Proteins in the Adult Rat Prostate Endocrinology, January 1, 2001; 142(1): 359 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Thomas and P.M. Speight Cell Adhesion Molecules and Oral Cancer Critical Reviews in Oral Biology & Medicine, January 1, 2001; 12(6): 479 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Rashid, M. G. Sanda, C. J. Vallorosi, J. Rios-Doria, M. A. Rubin, and M. L. Day Posttranslational Truncation and Inactivation of Human E-Cadherin Distinguishes Prostate Cancer from Matched Normal Prostate Cancer Res., January 1, 2001; 61(2): 489 - 492. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Wang, S. W. Hayward, A. A. Donjacour, P. Young, T. Jacks, J. Sage, R. Dahiya, R. D. Cardiff, M. L. Day, and G. R. Cunha Sex Hormone-induced Carcinogenesis in Rb-deficient Prostate Tissue Cancer Res., November 1, 2000; 60(21): 6008 - 6017. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Abate-Shen and M. M. Shen Molecular genetics of prostate cancer Genes & Dev., October 1, 2000; 14(19): 2410 - 2434. [Full Text]
|
|
|
|
|
|
S. Gupta, N. Ahmad, S. R. Marengo, G. T. MacLennan, N. M. Greenberg, and H. Mukhtar Chemoprevention of Prostate Carcinogenesis by {{alpha}}-Difluoromethylornithine in TRAMP Mice Cancer Res., September 1, 2000; 60(18): 5125 - 5133. [Abstract] [Full Text]
|
|
|
|
|
|
K. Tomita, A. van Bokhoven, G. J. L. H. van Leenders, E. T. G. Ruijter, C. F. J. Jansen, M. J. G. Bussemakers, and J. A. Schalken Cadherin Switching in Human Prostate Cancer Progression Cancer Res., July 1, 2000; 60(13): 3650 - 3654. [Abstract] [Full Text]
|
|
|
|
|
|
H. Kuniyasu, P. Troncoso, D. Johnston, C. D. Bucana, E. Tahara, I. J. Fidler, and C. A. Pettaway Relative Expression of Type IV Collagenase, E-cadherin, and Vascular Endothelial Growth Factor/Vascular Permeability Factor in Prostatectomy Specimens Distinguishes Organ-confined from Pathologically Advanced Prostate Cancers Clin. Cancer Res., June 1, 2000; 6(6): 2295 - 2308. [Abstract] [Full Text]
|
|
|
|
|
|
R. Thomas, L. D. True, J. A. Bassuk, P. H. Lange, and R. L. Vessella Differential Expression of Osteonectin/SPARC during Human Prostate Cancer Progression Clin. Cancer Res., March 1, 2000; 6(3): 1140 - 1149. [Abstract] [Full Text]
|
|
|
|
|
|
L.-C. Li, R. M. Chui, M. Sasaki, K. Nakajima, G. Perinchery, H. C. Au, D. Nojima, P. Carroll, and R. Dahiya A Single Nucleotide Polymorphism in the E-cadherin Gene Promoter Alters Transcriptional Activities Cancer Res., February 1, 2000; 60(4): 873 - 876. [Abstract] [Full Text]
|
|
|
|
|
|
N. L. Tran, R. B. Nagle, A. E. Cress, and R. L. Heimark N-Cadherin Expression in Human Prostate Carcinoma Cell Lines : An Epithelial-Mesenchymal Transformation Mediating Adhesion withStromal Cells Am. J. Pathol., September 1, 1999; 155(3): 787 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. F. Jarrard, S. Sarkar, Y. Shi, T. R. Yeager, G. Magrane, H. Kinoshita, N. Nassif, L. Meisner, M. A. Newton, F. M. Waldman, et al. p16/pRb Pathway Alterations Are Required for Bypassing Senescence in Human Prostate Epithelial Cells Cancer Res., June 1, 1999; 59(12): 2957 - 2964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Rondinelli and J. V. Tricoli CLAR1, a Novel Gene That Exhibits Enhanced Expression in Advanced Human Prostate Cancer Clin. Cancer Res., June 1, 1999; 5(6): 1595 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Day, X. Zhao, C. J. Vallorosi, M. Putzi, C. T. Powell, C. Lin, and K. C. Day E-cadherin Mediates Aggregation-dependent Survival of Prostate and Mammary Epithelial Cells through the Retinoblastoma Cell Cycle Control Pathway J. Biol. Chem., April 2, 1999; 274(14): 9656 - 9664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Efstathiou, D. Liu, J. M. D. Wheeler, H. C. Kim, N. E. Beck, M. Ilyas, A. J. Karayiannakis, N. J. McC. Mortensen, W. Kmiot, R. J. Playford, et al. Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells PNAS, March 2, 1999; 96(5): 2316 - 2321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ruijter, C. van de Kaa, G. Miller, D. Ruiter, F. Debruyne, and J. Schalken Molecular Genetics and Epidemiology of Prostate Carcinoma Endocr. Rev., February 1, 1999; 20(1): 22 - 45. [Abstract] [Full Text]
|
|
|
|
|
|
H. Kuniyasu, L. M. Ellis, D. B. Evans, J. L. Abbruzzese, C. J. Fenoglio, C. D. Bucana, K. R. Cleary, E. Tahara, and I. J. Fidler Relative Expression of E-Cadherin and Type IV Collagenase Genes Predicts Disease Outcome in Patients with Resectable Pancreatic Carcinoma Clin. Cancer Res., January 1, 1999; 5(1): 25 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Lopez-Otin and E. P. Diamandis Breast and Prostate Cancer: An Analysis of Common Epidemiological, Genetic, and Biochemical Features Endocr. Rev., August 1, 1998; 19(4): 365 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. N. Nupponen, L. Kakkola, P. Koivisto, and T. Visakorpi Genetic Alterations in Hormone-Refractory Recurrent Prostate Carcinomas Am. J. Pathol., July 1, 1998; 153(1): 141 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Monier-Gavelle and J.-L. Duband Cross Talk between Adhesion Molecules: Control of N-cadherin Activity by Intracellular Signals Elicited by {beta}1 and {beta}3 Integrins in Migrating Neural Crest Cells J. Cell Biol., June 30, 1997; 137(7): 1663 - 1681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Monier-Gavelle and J. Duband Control of N-cadherin-mediated intercellular adhesion in migrating neural crest cells in vitro J. Cell Sci., January 12, 1995; 108(12): 3839 - 3853. [Abstract] [PDF]
|
|
|
|
|
|
J. DePasquale, W. Samsonoff, and J. Gierthy 17-beta-Estradiol induced alterations of cell-matrix and intercellular adhesions in a human mammary carcinoma cell line J. Cell Sci., January 5, 1994; 107(5): 1241 - 1254. [Abstract] [PDF]
|
|
|
|
 |
|
 W.B. Isaacs, G.S. Bova, R.A. Morton, M.J.G. Bussemakers, J.D. Brooks, and C.M. Ewing Genetic Alterations in Prostate Cancer Cold Spring Harb Symp Quant Biol, January 1, 1994; 59(0): 653 - 659. [Abstract] [PDF]
|
|
|
|
|
|
P Navarro, E Lozano, and A Cano Expression of E- or P-cadherin is not sufficient to modify the morphology and the tumorigenic behavior of murine spindle carcinoma cells. Possible involvement of plakoglobin J. Cell Sci., January 8, 1993; 105(4): 923 - 934. [Abstract] [PDF]
|
|
|
|
|
|
T. Kitada, E. Miyoshi, K. Noda, S. Higashiyama, H. Ihara, N. Matsuura, N. Hayashi, S. Kawata, Y. Matsuzawa, and N. Taniguchi The Addition of Bisecting N-Acetylglucosamine Residues to E-cadherin Down-regulates the Tyrosine Phosphorylation of beta -Catenin J. Biol. Chem., January 5, 2001; 276(1): 475 - 480. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
